CLR-125

N/A

Report date: 2026/01/04 20:00:05

NME

Base Information

Drug NameCLR-125

Drug Alias NameCLR-125

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Iodine > 125IRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasm MetastasisTriple Negative Breast NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCellectar Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms

Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A